| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $4.46B | +7.3% |
| Cost of Revenue | $2.18B | +3.3% |
| Gross Profit | $2.28B | +11.5% |
| R&D Expense | $1.01B | +7.0% |
| SG&A Expense | $449.1M | -4.1% |
| Operating Income | -$53.7M | +93.9% |
| Pre-tax Income | -$88.6M | +91.1% |
| Income Tax | $20.8M | +11.1% |
| Net Income | -$109.4M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $421.3M | -35.8% |
| Accounts Receivable | $588.5M | +4.6% |
| Current Assets | $3.45B | -29.7% |
| Total Assets | $9.87B | -15.0% |
| Current Liabilities | $820.2M | +11.1% |
| Long-term Debt | $990.6M | +0.2% |
| Total Liabilities | $1.91B | +1.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $716.2M | +72.7% |
| Investing Cash Flow | $1.37B | +499.7% |
| Financing Cash Flow | -$2.31B | -259.2% |
| +89.2% |
| EPS (Basic) | -$0.66 | +88.1% |
| EPS (Diluted) | -$0.66 | +88.1% |
| Stockholders' Equity |
| $7.95B |
| -18.3% |